Hofseth BioCare ASA logo

Hofseth BioCare ASA

NEW
OSL:HBC (Norway)  
kr 1.35 +0.035 (+2.66%) Jul 31
At Loss
Market Cap:
kr 639.10M ($ 67.48M)
Enterprise V:
kr 942.58M ($ 99.52M)
Volume:
453.44K
Avg Vol (2M):
181.82K
Trade In:
Volume:
453.44K
At Loss
Avg Vol (2M):
181.82K

Hofseth BioCare ASA’s share price is kr1.35. Its GF Value is kr2.27. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Hofseth BioCare ASA stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: kr1.35 GF Value Price/GF Value
Current kr2.27 0.59
Next FY1 End kr2.45 0.55
Next 12 Month kr2.77 0.49
Next FY2 End kr2.93 0.46
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Hofseth BioCare ASA's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Hofseth BioCare ASA's stock price and Book Value per share, with a coefficient of 68%. Hofseth BioCare ASA’s stock price shows no significant correlation with Earnings without NRI per share. Hofseth BioCare ASA’s stock price shows no significant correlation with Operating Cash Flow per share. Hofseth BioCare ASA’s stock price shows no significant correlation with Revenue per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies